Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Pfizer Inc. et al v. Sandoz Inc.
Case Number:
1:09-cv-00742
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
December 20, 2011
Pfizer, Sandoz Agree To End Caduet Patent Fight
A Delaware federal judge on Monday dismissed consolidated patent litigation between Pfizer Inc. and Sandoz Inc. over Pfizer's blood pressure and cholesterol drug Caduet, after they agreed to drop the dispute.
-
February 10, 2010
Pfizer, Sandoz Patent Spat Over Caduet Heads To Del.
Pfizer Inc. has won its bid to transfer to Delaware federal court a patent infringement case over Sandoz Inc.'s abbreviated new drug application to manufacture a generic version of blood pressure and cholesterol reducer Caduet.